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Abstract
We have established a heart slice primary culture, which allows us to mechanically separate distinct cardiac cell populations and assay
their relative mitogenic and trophic effects on cardiac myocyte proliferation and survival. Using this system, we have found that a signal(s)
from the epicardium, but not the trabeculae and endocardium, is required in embryonic day 10 (E10) chick heart slices for continued cardiac
myocyte proliferation and survival. An examination of potential epicardial growth or trophic factors has revealed that blockade of either
retinoic acid (RA) or erythopoietin (epo) signaling from the epicardium inhibits cardiac myocyte proliferation and survival. The blockade
of cardiac myocyte proliferation following administration of an RA antagonist can be rescued by exogenous epo. Conversely, the blockade
of cardiac myocyte proliferation following administration of an anti-epo receptor antisera can be rescued by exogenous RA. Thus, our
findings suggest that RA and epo signals work in parallel to support myocardial cell proliferation. In addition, we have found that these
factors do not act directly on myocardial cells. Rather, they induce another soluble factor(s) in the epicardium that directly regulates
proliferation of cardiac myocytes. We therefore postulate that the epicardium controls normal heart growth in ventricular segments of the
embryonic chick heart by secreting a cardiac myocyte mitogen whose expression (or activity) is regulated by both RA and erythropoietin
signaling.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Cardiac myocytes proliferate until around birth in the
mouse (Soonpaa et al., 1996) and the rat (Li et al., 1996) or
hatching in the chick (Li et al., 1997). The major prolifer-
ation-driven increase in thickness of the ventricular wall of
the heart takes place from E11.5 to E14.5 in the mouse
(Erokhina, 1968), and from E8 to E14 in the chick
(Rychterova, 1971, 1978). The maintained proliferation of
cardiac myocytes at these embryonic stages results in the
expansion of the ventricular wall. The region of the heart
that shows the highest rate of proliferation lies adjacent to
the epicardium (Tokuyasu, 1990) and is termed the compact
zone. Postnatally, the further increase in the size of the heart
is generally attributed to hypertrophy of cardiac myocytes
(Li et al., 1996, 1997; Soonpaa et al., 1996). The precise
mechanisms that regulate cardiac myocyte cell proliferation
are largely unknown. By analyzing the clonal progeny of
chick heart cells infected with viruses encoding dominant-
negative FGF-receptors, Mikawa and coworkers have dem-
onstrated an FGF-dependent, early phase and an FGF-inde-
pendent, late phase for cardiac myocyte proliferation (Mima
et al., 1995). Whereas cardiac myocytes infected at E3 with
a retrovirus encoding a dominant-negative FGF-receptor
gave rise to small colonies of cells relative to a control
retrovirus infection, cardiac myocytes infected at E7, during
the time of ventricular wall expansion, gave rise to normal
size colonies. This finding suggested that only an early
phase of cardiac myocyte proliferation or survival requires
FGF signals (Mima et al., 1995).
In addition to FGF, a number of other molecules have
been implicated as playing a role in cardiac myocyte pro-
liferation. Several knockout-mice have been described that
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show a hypoplastic cardiac phenotype associated with a thin
ventricular wall, or reduced trabeculation, suggesting a pos-
sible role in cardiac myocyte proliferation for such diverse
molecules as: RAR (Kastner et al., 1997), RXR (Sucov et
al., 1994), VCAM-1 (Kwee et al., 1995), -integrin (Yang
et al., 1995), erythropoietin (Wu et al., 1999), erythropoietin
receptor (Wu et al., 1999), neuregulin (Meyer and Birch-
meier, 1995), erbB2 (Lee et al., 1995), erbB4 (Gassmann et
al., 1995), N-myc (Moens et al., 1993), TEF-1 (Chen et al.,
1994), WT-1 (Kreidberg et al., 1993), gp 130 (Yoshida et
al., 1996), Jak2 (Neubauer et al., 1998), -ARK (Jaber et
al., 1996), p300 (Yao et al., 1998), Pax-3 (Li et al., 1999),
and FOG-2 (Tevosian et al., 2000). However, it is unclear
whether the affected gene products in these mutant mice
directly control cardiac wall expansion per se, as it is pos-
sible that indirect mechanisms, such as a disturbance of
angiogenesis or an upstream obstruction of blood flow, may
result in a hypoplastic ventricular phenotype as well. In the
case of VCAM-1 (Kwee et al., 1995), -integrin (Yang et
al., 1995) or FOG-2 (Tevosian et al., 2000) deficient ani-
mals, it was noted that the interaction between the epicar-
dium and the myocardium was partially disrupted. The
resultant thin ventricular wall in these animals (Kwee et al.,
1995; Tevosian et al., 2000; Yang et al., 1995) is consistent
with the notion that communication between the epicardium
and myocardium may play a role in the expansion of the
ventricular wall. Indeed, an experimental delay of epicardial
growth over the myocardium in chick embryos similarly
leads to a thin myocardial wall (Gittenberger-de Groot et al.,
2000; Perez-Pomares et al., 2002). Interestingly the require-
ment for RXR (Sucov et al., 1994), gp 130 (Yoshida et al.,
1996), and the erythropoietin receptor (Wu et al., 1999) to
promote the expansion of the compact zone is non-cell-
autonomous with respect to the cardiac myocyte lineage
Fig. 1. Cardiac myocytes proliferate in slice-culture. (A) Schematic drawing of heart slices used throughout this study. Coronal sections through the
ventricular region of a E10 chick heart (HH stage 36) were dissected and cultured as an intact slice or, in some cases, cultured after removal of either the
epicardium or the endocardium and trabeculae. Dotted lines indicate lines of dissection to remove either the epicardium or trabeculae and endocardium from
the remaining heart slice. (B) Cardiac myocytes continue to express myosin heavy chain in explant culture. E10 chick heart slice cultures were cultured for
either 2 or 4 days (2d, 4d) as indicated. The cultures were harvested and immunostained for myosin heavy chain (MHC; a and b) and assayed for DNA content
by DAPI staining (c and d). Note that the vast majority of the cells in the heart slice are MHC-positive at all culture periods. (C) Cardiac myocytes in heart
slice culture continue to divide for at least 4 days. E10 chick heart slices were explanted, cultured for increasing periods of time, and labeled with BrdU for
15 h prior to harvesting. The sequence of reagent additions is outlined in the upper part of the figure. Immunofluorescence for BrdU incorporation (a–c) and
DAPI staining (d–f) in explants that were harvested after 2 (2d), 3 (3d), or 4 (4d) days of culture. (D) Quantitation of BrdU incorporation time course in
cardiac explant cultures.
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(Chen et al., 1998; Hirota et al., 1999; Tran and Sucov,
1998; Wu et al., 1999), suggesting that these signaling
molecules may be required in cells other than cardiac myo-
cytes to promote proliferation of this cell type.
To directly study the influence of the epicardium or
endocardium on cardiac myocyte proliferation, we have
employed a heart slice culture system that allows us to
mechanically separate the epicardium or endocardium/tra-
beculae from the ventricular wall. We have found that a
signal(s) from the epicardium, but not from the endocar-
dium, is required for cardiac myocyte proliferation. We
have investigated whether retinoic acid or erythropoietin
signaling contributes to the mitogenic action of the epicar-
dium on ventricular myocytes. Here, we show that admin-
istration of either the RAR antagonist, Ro-415253, or an
anti-epo receptor antibody to heart slice cultures mimics the
Fig. 2. The epicardium, neither trabeculae nor endocardium, is required for cardiac myocyte proliferation and for survival. (A) Either intact E10 chick heart
slices (a–d) or slices lacking either epicardium (e–h) or trabeculae and endocardium (i and j) were explanted, cultured for 3 or 4 days as indicated, and DNA
synthesis was assayed by BrdU incorporation. The sequence of reagent additions is outlined in the upper part of the figure. Immunofluorescence for BrdU
incorporation (a, b, e, f, i) and DAPI staining (c, d, g, h, j) are shown. Nuclei incorporated BrdU in both the intact heart slice (a and b) and in the heart slice
lacking the endocardium and trabeculae (i), but failed to incorporate significant levels of BrdU in the heart slice lacking the epicardium (e and f). Note also
that the number and appearance of the nuclei is dramatically reduced after removal of the epicardium for 4 days (h), but not after culture of either the intact
heart slice (d) or after removal of the endocardium and trabeculae (j) for the same period of time. (B) Quantitation of BrdU incorporation in either the intact
cardiac slice culture or in cardiac slice cultures lacking either the epicardium or the trabeculae and endocardium. Cultures were harvested after 3 or 4 days
as indicated. (C) Density of nuclei in either the intact cardiac slice culture or in cardiac slice cultures lacking either the epicardium or the trabeculae and
endocardium. Cultures were harvested after 3 or 4 days as indicated.
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effect of removal of the epicardium and blocks cardiac
myocyte proliferation. Furthermore, we demonstrate that
inhibition of cardiac myocyte proliferation by Ro-415253
can be overcome by the addition of erythropoietin (epo),
and that inhibition of cardiac myocyte proliferation by the
anti-epo receptor antibody can be overcome by addition of
exogenous RA. Finally, we show that epo and RA do not
directly induce proliferation of cardiac myocytes but rather
induce the secretion of a soluble cardiac myocyte mitogen
from the epicardium. Together, our findings support a
model in which a network of retinoic acid and epo signals in
the epicardium induce the expression (or activity) of a
mitogen(s) that directly regulates cardiac myocyte prolifer-
ation.
Materials and methods
Embryonic heart tissue
M159 fertilized eggs were incubated in a humidified egg
incubator at 37°C. The day the incubation started was de-
fined as E1. After 10 or 11 days of incubation, the chicken
embryos were harvested and staged according to Ham-
burger and Hamilton (1951). Whole hearts were dissected
from HH stage 36 chick embryos on ice in PBS  penicil-
lin/streptomycin (50 g per ml each).
Light microscopic immunocytochemistry
Hearts were immersed in fixative containing 4% parafor-
maldehyde, 4% sucrose, 2 mM CaCl2, 200 mM Hepes–
NaOH, pH 7.4, or 4% paraformaldehyde in PBS, pH 7.4, for
1 h. The fixed tissue was infiltrated with sucrose, frozen in
Tissue-Tek, and 5- to 7-m cryosections were prepared and
processed as described (Aaku-Saraste et al., 1997), except
that the sections were collected on Superfrost-Plus slides
rather than on Gelatin-coated slides, and the blocking me-
dium contained 3% fetal calf serum instead of 0.05% BSA.
In the case of anti-BrdU immunofluorescence, cryosections
were then processed as described by Novitch et al. (1996).
The primary antibodies used and their dilution/concentra-
tion were as follows: mouse mAb MF-20 against sarcomeric
myosins, ascites supernatant 1:10; mouse mAb G3G4
against BrdU, hybridoma supernatant 1:200 (Developmen-
tal Studies Hybridoma Bank, Iowa City, IA). The secondary
antibodies used and their dilution/concentration were as
follows: TRITC-conjugated goat anti-mouse 1:200, Cy-2 or
Cy-3-conjugated goat anti-mouse 1:200 (The Jackson Lab-
oratory, Bar Harbor, ME). Sections were mounted with
Moviol and/or observed directly with a Zeiss Axioskop
microscope. Pictures were taken with a Toshiba 3CCD
camera by using Phase 3 Imaging software (www.p3i.com).
Slice culture
Prior to the dissection, 5–10% low-melting agarose was
dissolved in PBS at 65°C for 30 min. Chick hearts were
removed from E10 (HH stage 36) embryos and the atria
were removed. Blood cells were carefully rinsed from the
lumen of the ventricles, and the hearts were briefly stored in
PBS on ice. The hearts were positioned in Peel-A-Way
plastic molds (VWR) in agarose initially cooled to room
temperature, then rapidly chilled and solidified on ice.
Blocks of agarose containing embedded hearts were cut out
and fixed onto a specimen holder. The specimen holder was
then cooled on ice, and sections were subsequently cut in
ice-cold PBS  penicillin/streptomycin with a Vibratome
(Leica VT1000M). We found that the use of nonundulating
razor blades (e.g., Dickinson, NJ) was critical in obtaining
thin slices. We regularly cut 150-m slices because the
number and quality of the slices dropped with thinner sec-
tions; however, it was possible to obtain living slices that
were 50 m thin. Floating slices were then collected and
typically cultured on a petri dish in a drop of at least 100 l
of medium (DMEM with 10% FBS) at 37°C, 5% CO2.
BrdU (10 m) was added to the culture medium at the
indicated time points. The following reagents were used:
retinoic acid was a mixture of all-trans (5  107 M) and
cis-retinoic acid (5  109 M), rabbit polyclonal antiserum
against the Epo Receptor or Ephrin B1 (control antiserum)
was diluted 1:100 (Santa Cruz), Ro415253 (a kind gift from
Dr. A. Pignatello, Hoffman-LaRoche) was employed at 1
106 M.
Epicardial cell culture and immunocytochemistry
Embryonic day 10 hearts were removed from the em-
bryo and placed onto ice-cold PBS with penicillin/strep-
tomycin (GIBCO). Atria and outflow tracts were re-
moved, and the ventricular portion was cut into four
pieces. Tissue chunks were cultured in DMEM/10% FBS/
pen-strep for 4 days to ensure sufficient growth of “halo”
cells. After culture, the remaining heart tissue was re-
moved. Three PBS rinses were performed after each step.
Cells were fixed in 1:1 methanol:acetone for 10 min at
20°C and then blocked in 4% normal goat serum, 1%
FBS, 0.1% Triton X-100 for 30 min at room temperature.
Primary antibodies were diluted in PBS as follows and
incubated at 4°C overnight: Wilms Tumor 1 (C-19, Santa
Cruz, sc-192) 1:100, Cytokeratin (Dako, Z0622) 1:300,
RALDH2 (generously provided by Dr. Ursula Dra¨ger)
1:2000. Secondary antibodies were diluted in PBS as
follows and incubated for 1 h at room temperature: bio-
tinylated donkey anti-rabbit (Jackson, 711065152) 1:300,
Texas-red-Conjugated streptavidin (Jackson, 016070084)
1:300, and Dapi 1:500. Cells were observed with a Zeiss
Axioscop microscope.
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Epicardial cell-conditioned medium
E10 chick heart slices were cultured in 100 l of me-
dium, consisting of DMEM with 10% FBS, at 37°C, 5%
CO2. After several days, the slice consisting of cardiac
myocytes was removed carefully so that a “halo” of non-
cardiac myocyte cells that had migrated out of the slice
remained attached to the culture dish. We suspect that this
“halo” of noncardiac mycocytes represents epicardial cells
as migration of cells out of the heart slice was not observed
in slices lacking the epicardium and the cells expressed
various epicardial cell markers, including Wilm’s Tumor-1,
RALDH-2, and cytokeratin (see Results). The epicardial
cells were either maintained in the absence or presence of
Epo (2 U/ml), and the epicardial cell-conditioned medium
(ECCM) was harvested every 2 days.
Results
Cardiac myocytes proliferate in slice-cultures
from young hearts
To monitor the effects of the epicardium or the endocar-
dium and trabeculae on proliferation and survival of cardiac
myocytes, we established an organ culture system for E10
chick hearts (i.e., HH stage 36) which have been cultured in
vitro. Hearts from this stage chick embryo were excised, the
atria were removed, the remaining ventricles were embed-
ded in agarose, 100- to 150-micron transverse slices were
made, and the slices were cultured. A schematic of such a
slice is depicted in Fig. 1A. Similar to cardiac cell cluster
cultures grown in monolayer (Polinger, 1973), a subpopu-
lation of cells migrated from the slices and formed a halo-
like structure on the periphery of the slice (data not shown).
These migratory cells fail to express the cardiac myocyte
marker myosin heavy chain (MHC) (data not shown), and
thus appear to represent a cell population derived from
nonmuscle tissue. In contrast, over 99% of the nonmigratory
cells remaining in the slice were MHC-positive (Fig. 1B).
BrdU incorporation over 4 days of culture indicated that the
cardiac myocytes continued to proliferate during the entire
culture period (Fig. 1C and D).
The epicardium, but neither the trabeculae nor
endocardium, is required for cardiac myocyte
proliferation and survival
To examine the role of the epicardium, trabeculae, and
endocardium on proliferation and survival of the myocar-
dium, we dissected E10 chick heart slices and cultured the
myocardium either with or without these adjacent tissues.
As schematically outlined in Fig. 1A, either the epicardium
or endocardium and trabeculae were mechanically dissected
away from the remaining heart slice, which was then cul-
tured for several days and assayed for proliferation. As the
epicardium is only one to two cells thick, we were able to
remove this tissue without inflicting significant damage to
the majority of the myocardium. We observed that removal
of the epicardium dramatically reduced the apparent number
of noncardiac “halo”-forming cells that migrated out of
intact slices (data not shown). This effect was not seen
following removal of the endocardium and trabeculae, sug-
gesting that the migratory cells were epicardial in origin.
Removal of the epicardium resulted in a dramatic loss of
BrdU incorporation in the myocardium between the second
and third days of culture (Fig. 2A, compare a, c with e, g;
Fig. 2B). After 3 days of culture, the number and appear-
ance of the nuclei in heart slices devoid of epicardium was
comparable to that in intact control slices. However, after 4
days of culture, removal of the epicardium resulted in a
dramatic reduction in the number of DAPI-staining nuclei
(in many cases, a decrease of greater than 90% relative to
the intact control slice) (Fig. 2A, compare d with h; Fig.
2C). It seems unlikely that the lack of BrdU incorporation
throughout the myocardium in the absence of the adjacent
epicardium was due to removal of some of the myocardium
along with the epicardium, as cells throughout the entire
thickness of the heart slice, and not just adjacent to the
epicardium, are capable of incorporating BrdU in the pres-
ence but not in the absence of the adjacent epicardium (Fig.
2A, compare a and b with e and f). In contrast to the absence
of myocardial cell proliferation following removal of the
epicardium, neither the proliferation nor survival of cardiac
myocytes was significantly affected following the removal
of the endocardium and trabeculae (Fig. 2A, i and j; Fig. 2B
and C). These findings suggest that signals from epicardial
cells are required for cardiac myocyte proliferation as well
as for survival.
Retinoic acid is required for cardiac myocyte
proliferation and survival
To identify molecules that might be required for cardiac
myocyte proliferation and survival, we examined the effect
of secreted molecules known to be expressed in the epicar-
dium. We first tested the involvement of retinoic acid (RA),
which has recently been shown to be synthesized in the
epicardium (Moss et al., 1998) and to modulate ventricular
cell proliferation via the RXR nuclear hormone receptor in
a non-cell-autonomous fashion (Chen et al., 1998; Tran and
Sucov, 1998). Intact heart slices were cultured with or
without the RA antagonist, Ro415253, and assayed for
proliferation. Three days following administration of the
RA antagonist, incorporation of BrdU into cardiac myo-
cytes was dramatically inhibited, while the number and
appearance of the nuclei was comparable to that in control
slices (Fig. 3A, compare a, c with e, g; data quantified in
Fig. 3B and C). After 5 days of culture, addition of
Ro415253 resulted in a reduction in the number of nuclei
and nuclear degradation (Fig. 3A, compare b, d, with f, h;
data quantified in Fig. 3B and C). Thus, administration of
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the RA antagonist, Ro415253, resulted in a phenotype sim-
ilar to that following removal of the epicardium.
Exogenous retinoic acid does not overcome the inhibition
of cardiac myocyte proliferation following removal of the
epicardium
Moss et al. (1998) have shown that cardiac myocytes
respond to an RA signal, since an RA-stimulated reporter
transgene is strongly expressed in the myocardium from
E12.5 onwards in the mouse. Moreover, this same group
showed that cardiac expression of the RA biosynthetic en-
zyme, RALDH2, occurs predominantly in the epicardium
from E11.5 onwards, suggesting that the epicardium may be
the relevant source for RA in the embryonic heart. To
investigate whether RA secreted from the epicardium might
directly regulate cardiac myocyte proliferation, we exam-
ined whether exogenous RA could rescue proliferation of
myocardial cells in heart slices cultured in the absence of
the epicardium (Fig. 4). Administration of exogenous RA
failed to rescue cardiac myocyte proliferation in heart slices
cultured in the absence of the epicardium (Fig. 4A, compare
e, g with f, h; and Fig. 4B). Because RA cannot substitute
for the epicardial signal that drives myocardial cell prolif-
Fig. 3. Retinoic acid is required for cardiac myocyte proliferation and for survival. (A) Chick heart slices were cultured for 3 or 5 days either in the absence
(a–d) or the presence (e–h) of the RA antagonist Ro415253. DNA synthesis was assayed by BrdU incorporation. Immunofluorescence for BrdU (a, b, e, f)
and DAPI staining (c, d, g, h) is shown. The sequence of reagent additions is outlined in the upper part of the figure. Note that incorporation of BrdU is
dramatically reduced in the heart slices cultured in the presence of the RA antagonist Ro415253 (Ro) for either 3 or 5 days (e, f). The number of nuclei
in the heart slice cultured in the presence of the RA antagonist Ro415253 (Ro) is comparable with the number of nuclei in the untreated slice after 3 days
of culture (compare c with g), but decreases after 5 days of culture in the presence of the RA antagonist Ro415253 (compare d with h). (B) Quantitation of
BrdU incorporation in intact cardiac slices cultured in either the absence or the presence of the RA antagonist Ro415253 (Ro) for 3 or 5 days. (C) Density
of nuclei in intact cardiac slices cultured in either the absence or the presence of the RA antagonist Ro415253 (Ro) for 3 or 5 days.
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Fig. 4. Exogenous retinoic acid does not overcome the inhibition of cardiac myocyte proliferation following removal of the epicardium. (A) Either intact heart
slices or those lacking the epicardium were cultured for 3 days either in the absence (RA) or the presence (RA) of retinoic acid. The sequence of reagent
additions is outlined in the upper part of the figure. Immunofluorescence for BrdU (a, b, e, f) and DAPI staining (c, d, g, h) are shown. Note that the nuclear
staining for BrdU is dramatically decreased in heart slices lacking the epicardium that have been cultured in either the absence or the presence of exogenous
RA (e and f). (B) Quantitation of BrdU labeling in either intact cardiac slice cultures or in cardiac slices lacking the epicardium.
eration, yet RA signaling is apparently required for such
mitogenic activity (Fig. 3), it raised the possibility that RA
might act on the epicardium itself to induce the expression
(or activity) of a myocardial mitogen. Indeed, this scenario
would be consistent with prior work demonstrating that
RXR functions in a non-cell-autonomous fashion to pro-
mote expansion of the cardiac myocyte lineage in the com-
pact zone (Chen et al., 1998; Tran and Sucov, 1998).
Ectopic epo administration rescues myocardial cell
proliferation in heart cultures treated with the
retinoic acid antagonist, Ro415253
Because erythropoietin (epo) is highly expressed in the
epicardium, but not in the cardiac wall (Wu et al., 1999),
and mice lacking epo display a hypoplastic ventricle that is
reminiscent of that seen in RXR knock-out mice (Sucov et
al., 1994; Wu et al., 1999), we examined whether epo and
RA signaling might be involved in a common pathway
regulating cardiac myocyte proliferation. To explore this
issue, we examined whether the loss of cardiac myocyte
proliferation in heart slice cultures treated with the RA
antagonist, Ro415253, could be restored by administration
of exogenous epo. E10 chick heart slices were cultured with
Ro415253 in either the absence or presence of exogenous
epo, and cellular proliferation was assayed by BrdU incor-
poration. Whereas cultures treated with Ro415253 failed to
sustain myocardial DNA synthesis (Fig. 5A, c, and Fig. 5B),
those treated with Ro415253 plus epo maintained robust
myocardial DNA synthesis (Fig. 5A, e, and Fig. 5B). In
addition, epo also improved the survival of cardiac myo-
cytes following Ro415253 administration, as the number of
nuclei in cultures treated with the combination of epo plus
Ro415253 was not reduced as it was following Ro415253
treatment alone (Fig. 5A, compare b, d, and f). Because
exogenous epo reversed the loss of myocardial DNA syn-
thesis following Ro415253 administration, these findings
suggest that epo signals work either in parallel or down-
stream of RA signaling to promote myocardial cell prolif-
eration.
Exogenous epo administration, either in the absence or
presence of RA, fails to rescue cardiac myocyte
proliferation following removal of the epicardium
Because exogenous epo rescued cardiac myocyte pro-
liferation in heart slices cultured in the presence of an RA
antagonist, we examined whether exogenous epo could
similarly rescue cardiac myocyte proliferation in heart
slices cultured in the absence of the epicardium. Admin-
istration of exogenous epo, either in the absence or pres-
ence of RA, failed to promote myocardial cell prolifera-
tion in heart slices lacking the epicardium (Fig. 6A, a– h;
and Fig. 6B). These findings indicate that neither epo nor
RA signaling in myocardial cells (devoid of the adjacent
epicardium) is sufficient, either alone or in combination,
to promote myocardial cell proliferation in the absence of
the epicardium.
Fig. 5. Erythropoietin overcomes the inhibition of cardiac myocyte prolifer-
ation by retinoic acid receptor antagonists. (A) Chick heart slices were cultured
in either normal medium (a and b) or in medium containing either the RA
antagonist Ro415253 (Ro) alone (c and d) or the RA antagonist Ro415253
(Ro) plus erythropoietin (Epo; e and f). Immunofluorescence for BrdU (a, c, e)
and DAPI staining (b, d, f) are shown. The sequence of reagent additions is
outlined in the upper part of the figure. Note that the dramatic reduction of
BrdU labeling following treatment with the RA antagonist (Ro; c) is over-
come by the addition of erythropoietin (RoEPO; e). Note also that the
addition of erythropoietin (RoEPO; f) reverses the reduction in the number
of DAPI staining nuclei observed after administration of the RA antagonist
(Ro; d). (B) Quantitation of BrdU labeling in cardiac slices cultured in the
presence of the RA antagonist Ro415253 (Ro) in either the absence or pres-
ence of erythropoietin (Epo).
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Blockade of epo signaling blocks myocardial cell
proliferation in heart cultures
To investigate whether epo signaling was necessary to
promote cardiac myocyte proliferation in heart slice cul-
tures, we added a polyclonal antisera directed against the
epo-receptor to the cardiac explants. While control antisera
(directed against ephrin B2) failed to affect cardiac myocyte
proliferation, addition of anti-epo receptor antisera to the
culture medium blocked the incorporation of BrdU into
cardiac myoctes (Fig. 7A, a–f, and Fig. 7B). The inhibition
of myocardial DNA synthesis following addition of anti-epo
Fig. 6. Exogenous erythropoietin does not overcome the inhibition of cardiac myocyte proliferation following removal of the epicardium. (A) Either intact
heart slices (a and b) or slices lacking the epicardium (c–h) were cultured for 4 days in either the absence (a–d) or the presence of erythropoietin alone (Epo;
e and f) or erythropoietin and retinoic acid (EpoRA; g and h). BrdU was added to the medium for the last 2 days of culture. Immunofluorescence for
BrdU (a, c, e, g) and DAPI staining (b, d, f, h) are shown. The sequence of reagent additions is outlined in the upper part of the figure. (B) Quantitation of
BrdU incorporation in either intact heart slices or in heart slices lacking the epicardium that were cultured either in the absence or the presence of
erythropoietin (Epo) or erythropoietin and retinoic acid (EpoRA).
Fig. 7. Retinoic acid rescues the inhibition of cardiac myocyte proliferation by erythropoietin receptor antagonists. (A) Intact heart slices (a–h) were cultured
for 4 days either in either the absence (a and b) or the presence of either anti-Ephrin B2 (EB2) antibodies (c and d), anti-erythropoietin receptor (EpoR)
antibodies (e and f), or the combination of anti-erythropoietin receptor (EpoR) antibodies plus exogenous RA (g and h). BrdU was added for the last 2 days
of culture. Immunofluorescence for BrdU (a, c, e, g) and DAPI staining (b, d, f, h) is shown. The sequence of reagent additions is outlined in the upper part
of the figure. Note that BrdU labeling, which is dramatically reduced in explants containing anti-EpoR antibodies (e and f) is rescued in such cultures
following addition of exogenous RA (g and h). (B) Quantitation of BrdU labeling as described in (A).
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receptor antisera to the heart slice cultures is consistent with
prior findings that mice genetically engineered to lack either
epo or the Epo receptor show a thin ventricular wall (Wu et
al., 1999), and together suggest that epo signaling is neces-
sary for cardiac myocyte proliferation.
RA and epo act in parallel to induce a cardiac myocyte
mitogen
Our findings indicate that RA and epo work either in
series or in parallel to induce the synthesis of a cardiac
myocyte mitogen in epicardial cells. Epo-induced mitogenic
activity apparently does not require RA signals as exoge-
nous epo is able to rescue cardiac myocyte proliferation in
heart slice explants cultured in the presence of the RA
antagonist, Ro415253 (Fig. 5). To investigate whether RA-
induced cardiac myocyte proliferation requires concomitant
epo signaling, we evaluated whether exogenous RA was
able to restore DNA synthesis in heart slice explants cul-
tured in the presence of anti-epo receptor antisera. Addition
of RA to these cultures restored myocardial cell prolifera-
tion (Fig. 7A, g and h, and Fig. 7B), indicating that RA can
promote the synthesis of a myocardial mitogen indepen-
dently of epo signaling.
Epo induces the synthesis of a cardiac myocyte mitogen
in epicardial cells
While epo administration can rescue myocardial cell
proliferation in intact heart slices treated with a retinoic acid
antagonist (Fig. 5A, e and f) and RA administration can
similarly rescue cardiac myocyte proliferation in heart slices
treated with an anti-epo receptor antisera (Fig. 7A, g and h),
administration of either epo or RA (Fig. 6A, e and f; Fig.
4A, f and h, respectively) or the combination of both epo
and RA (Fig. 6A, g and h) failed to drive myocardial cell
proliferation in the absence of the epicardium. Together,
these findings suggest that epo and RA may modulate car-
diac myocyte proliferation by inducing the synthesis (or
activity) of a cardiac myocyte mitogen within the epicar-
dium itself. To test this hypothesis, we prepared conditioned
medium from epicardial cells that had been cultured either
in the absence or presence of epo, and asked whether such
conditioned medium could restore myocardial cell prolifer-
ation in heart slices devoid of epicardium. To prepare epi-
cardial cell cultures, an intact heart slice was cultured for 2
days, allowing epicardial cells to migrate out of the slice to
form a “halo” of cells surrounding the heart slice. We
believe that the “halo” of migratory cells was derived from
the epicardium as these migratory cells did not express the
cardiac myocyte marker, myosin heavy chain (data not
shown), yet expressed Wilm’s Tumor-1 (WT-1), cytokera-
tin, and RALDH-2 (Fig. 8), which are all highly expressed
in the epicardium and not in the myocardium (Fig. 8).
Furthermore, this “halo” of migratory cells was substan-
tially reduced in explants in which the epicardium had been
removed. After 2 days in culture, the remaining heart slice
was physically removed and the epicardial cells which had
migrated out from the slice remained attached to the culture
dish and were cultured for an additional 2 days to generate
epicardial cell-conditioned medium (ECCM).
While ECCM made from untreated epicardial cells failed
to restore myocardial cell proliferation in heart slices lack-
ing epicardium (Fig. 9A, g and h, Fig. 9B), conditioned
medium made from epo-treated epicardial cultures (ECCM
 epo) induced robust myocardial cell proliferation in these
same cultures (Fig. 9A, i and j, Fig. 9B). It is worth noting
that administration of epo in parallel with conditioned me-
dium from non-epo-treated epicardium (ECCM) failed to
induce proliferation in myocardial cultures (Fig. 9A, g and
h, Fig. 9B), indicating that the mitogenic effects of epo on
the myocardium are mediated via the epicardial cells. These
findings indicate that epo induces either the synthesis or
activity of a soluble cardiac myocyte mitogen within epi-
cardial cells and is consistent with the observation that the
cardiac-specific expression of the epo receptor is most pre-
dominant in the epicardium (Wu et al., 1999). We also
found that treatment of epicardial cells with RA could
similarly induce secretion of a cardiac myocyte mitogen
into the ECCM (data not shown), consistent with the notion
that epo and RA signals work in parallel to induce a cardiac
myocyte mitogen in the epicardium.
Discussion
RA and epo indirectly control cardiac myocyte cell
proliferation
By employing a heart slice culture system, we have
demonstrated that signals from the epicardium are necessary
and sufficient for myocardial cell proliferation. One such
signal is apparently retinoic acid (RA), as this substance is
both produced by the epicardium (Moss et al., 1998) and
administration of the RA-antagonist, Ro415253, to intact
heart slices can block myocardial cell proliferation (this
Fig. 8. “Halo” cells which migrate out of heart slice explants express epicardial cell markers. Sections through the ventricles of day 10 chick hearts (a–f) were
immunostained for expression of either Wilm’s Tumor-1 (WT-1; a), cytokeratin (c), or RALDH-2 (e). Sections were costained with DAPI to visualize the
nuclei (b, d, and f). Note that immunostaining of the various antigens is greatest in the epicardial layer on the outside of the myocardium. Explants of the
ventricles of day 10 chick hearts were cultured for 4 days. Explants containing the epicardium displayed a “halo” of cells which had migrated away from
the explant. The majority of the explant was physically removed, and the residual cells which had migrated out of the explant to form a “halo” of cells were
immunostained for expression of either Wilm’s Tumor-1 (WT-1; g), cytokeratin (i), or RALDH-2 (k), or immunostained without a primary antibody to
evaluate background staining (m). Cells were costained with DAPI to visualize the nuclei (h, j, l, and n).
343I. Stuckmann et al. / Developmental Biology 255 (2003) 334–349
344 I. Stuckmann et al. / Developmental Biology 255 (2003) 334–349
study). In addition, we have found that administration of
anti- epo receptor antisera can similarly block cardiac myo-
cyte proliferation in chick heart slice cultures. These results
indicate that RA and epo signaling are necessary for cardiac
myocyte proliferation in chick heart slice cultures, and are
consistent with data from knockout mice embryos that sug-
gested that these two signaling pathways might be necessary
for the expansion of the ventricular wall (Sucov et al., 1994;
Wu et al., 1999). Interestingly, administration of RA and
epo, either alone or in combination, to heart slices cultured
in the absence of the epicardium failed to rescue cardiac
myocyte proliferation in these cultures. Thus, although
these signals are necessary to support proliferation of the
myocardium, they are insufficient to directly drive cardiac
myocyte proliferation in the absence of the epicardium. A
resolution to this paradox has emerged from experiments
employing medium conditioned by epicardial cells. We
have found that either RA or epo induces the synthesis or
activity of a cardiac myocyte mitogen in epicardial cells,
which is secreted into epicardial cell conditioned medium.
That RA and epo fail to directly drive myocardial cell
proliferation, but rather promote the expression of a cardiac
myocyte mitogen in the epicardium, is consistent with prior
work indicating that both RXR (Sucov et al., 1994) and the
erythropoietin receptor (Wu et al., 1999) may be required in
cells other than cardiac myocytes to promote expansion of
the ventricular wall (Chen et al., 1998; Hirota et al., 1999;
Tran and Sucov, 1998; Wu et al., 1999). We think it is likely
that RA and epo induce the synthesis of a cardiac myocyte
mitogen(s) in epicardial cells via parallel pathways (out-
lined schematically in Fig. 10), as exogenous epo adminis-
tration can rescue myocardial proliferation in heart slices
exposed to the RA antagonist, Ro415253, and exogenous
RA administration can similarly rescue cardiac myocyte
proliferation in heart slices exposed to anti-epo receptor
antisera.
Cardiac myocyte proliferation requires physical contact
between the epicardium and myocardium
The epicardium is derived from cells of the proepicardial
serosa, which lies adjacent to the septum transversum (re-
viewed in Manner et al., 2001). Proepicardial cells migrate
over the outer surface of the heart to initially give rise to the
epicardium, and subsequently give rise to the endothelial
and smooth muscle cells of the coronary vessels and to
perivascular and intramyocardial fibroblasts (Manner,
1999). Blockade of proepicardial cell migration over the
heart in manipulated chick embryos results in a thin myo-
cardium (Gittenberger-de Groot et al., 2000; Perez-Pomares
et al., 2002), suggesting that epicardial factors are necessary
for myocardial cell proliferation. Furthermore, an involve-
ment of the epicardium in modulating cardiac myocyte
proliferation has been suggested by studies in mice engi-
neered to lack either V- cam (Kwee et al., 1995) or -inte-
grin (Yang et al., 1995). In these genetically altered mice,
there is a correlation between a loss of contact between the
epicardium and the myocardium and the subsequent devel-
opment of a hypoplastic ventricular wall around midgesta-
tion. However, it was not clear from any of these studies
employing either manipulated chick embryos or knockout
or transgenic mice whether signals from the epicardium
directly regulate ventricular wall expansion per se, or if the
ensuing cardiomyopathy results from a disturbance of car-
diac vascularization, which originates from the epicardium
(Komiyama et al., 1987), and is therefore secondary to the
decreased blood flow through the heart. Using the heart slice
culture technique, we have now been able to demonstrate
that soluble signals from the epicardium, induced by RA
and epo are required for cellular proliferation in the myo-
cardium. In contrast, removal of the endocardium and tra-
beculae from the heart slice cultures failed to affect myo-
cardial cell proliferation.
Epicardial retinoic acid is a pleiotropic regulator of
cardiac myocyte differentiation, survival, and
proliferation
Recently, the epicardium has been recognized to be the
principal source of RA in the developing heart, as
RALDH2, the rate-limiting enzyme in RA synthesis, is
highly expressed in the epicardium, but not in cardiac myo-
cytes (Moss et al., 1998). Although RA is solely produced
in the epicardium, expression of RA-responsive reporter
constructs in transgenic mice has indicated that both epicar-
dial and myocardial cells in the heart respond to RA sig-
naling during development (Moss et al., 1998). In this work,
we have demonstrated that, while RA signaling in the epi-
cardium is necessary for cardiac myocyte proliferation, this
is not because of a direct mitogenic effect of epicardial RA
on cardiac myocytes. Although the RA-antagonist,
Ro415253, dramatically reduced proliferation and the sub-
Fig. 9. Epo induces epicardial cells to secrete a soluble mitogen/survival factor for cardiac myocytes. (A) Either intact heart slices (a and b) or heart slices
lacking the epicardium (c–j) were cultured for 4 days either in the absence (a–d) or the presence (e–j) of erythropoietin (Epo). Medium conditioned by either
untreated epicardial cells (ECCM; g and h) or epicardial cells grown in Epo (ECCM  Epo; i and j) were added to the cultures as indicated. BrdU was added
for the last 2 days of culture. Immunofluorescence for BrdU (a, c, e, g, i) and DAPI staining (b, d, f, h, j) is shown. The sequence of reagent additions is
outlined in the upper part of the figure. Note that BrdU labeling, which is dramatically reduced following removal of the epicardium (c and d), is rescued
by the addition of epicardial cell medium conditioned in the presence of epo (ECCM  Epo; i and j). Note also that the addition of epicardial cell medium
conditioned in the presence of epo (ECCM  Epo; i and j) reverses the reduction in the number of nuclei observed after removal of the epicardium (c and
d). (B) Quantitation of BrdU labeling in either intact heart slices or in heart slices lacking the epicardium that were cultured either in the absence or presence
of Epo, plus either (ECCM) or (ECCM  Epo).
345I. Stuckmann et al. / Developmental Biology 255 (2003) 334–349
346 I. Stuckmann et al. / Developmental Biology 255 (2003) 334–349
sequent survival of cardiac myocytes in slice culture in the
presence of an intact epicardium, RA by itself could not
substitute for the epicardium. This finding suggests that RA
secreted by the epicardium either works in concert with
another epicardial factor(s) to promote myocardial cell pro-
liferation, or that RA induces the synthesis of a distinct
cardiac myocyte mitogen within the epicardium itself. The
idea that RA signaling in noncardiac myocytes is necessary
to promote myocardial cell proliferation is supported by two
recent studies: The Chien and Sucov laboratories have re-
cently demonstrated that mice with a cardiac myocyte-
specific deletion of RXR fail to develop hypoplastic hearts
(Chen et al., 1998) and that cardiomyocytes deficient in
RXR develop normally and contribute to the ventricular
chamber wall in chimeric mice embryos composed of mu-
tant and wild-type cells (Tran and Sucov, 1998). Together
with prior work indicating that RXR signaling is necessary
for ventricular compact zone expansion (Sucov et al., 1994),
these studies, plus our new data, indicate that RA signals
work in noncardiac myocytes to promote proliferation of
this cell type. Indeed, our findings are consistent with a
recent study from Henry Sucov’s group, which has found
that RXR function in the epicardium is necessary for this
tissue to secrete a cardiac myocyte mitogen (Chen et al.,
2002).
Epo signaling in the epicardium induces the synthesis
or expression of a cardiac myocyte mitogen
in epicardial cells
Genetically engineered mice which lack either epo or the
epo-receptor (epo-R) have recently been shown to develop
a hypoplastic heart phenotype in addition to defects in
erythropoiesis at midgestation (Wu et al., 1999). Interest-
ingly, the epo-receptor is expressed in the epicardium, but
not in cardiac myocytes (Wu et al., 1999), suggesting that
epo signaling in cells other than cardiac myocytes are nec-
essary for normal cardiac growth. In heart slice cultures, we
found that administration of epo failed to rescue cardiac
myocyte proliferation following removal of the epicardium,
suggesting that epo does not directly induce myocardial cell
proliferation. In contrast, conditioned medium from epo-
treated epicardial cells, but not from non-epo-treated epi-
cardial cells, was able to rescue myocardial cell prolifera-
tion in heart slices that lacked the epicardium. In light of
these findings, we propose that the observed hypoplastic
heart phenotype in epo/ and epo-receptor/ mice may
be due to the requirement for epo signaling in the epicar-
dium to promote the expression or activity of a cardiac
myocyte mitogen in the epicardial cells themselves.
Our results suggest that the control of myocardial growth
is regulated by the activity of both RA and epo signaling
pathways in the epicardium, which in turn controls the
expression or activity of a myocardial mitogen(s) which is
secreted by the epicardium (outlined in Fig. 10). That the
control of myocardial cell proliferation is mediated by such
a complex chain of molecular intermediaries is perhaps not
surprising in view of the pleiotropic effects of RA and epo
signaling, and the need for both spatially and temporally
precise control of proliferation in the developing heart. In
support of this hypothesis, it is known that the epo-receptor
is expressed in the mouse epicardium from E10.5 to E13.5
(Wu et al., 1999), coincident with the relatively massive
growth of the ventricular wall from E11.5 in mouse
(Erokhina, 1968). In contrast, the overall responsiveness to
RA signaling in the heart, as judged by expression of reti-
noic acid receptors, is maintained for a significantly longer
period of time (Dolle et al., 1990). Thus, by constraining the
time of expression of the epo-receptor in the epicardium, the
consequence of RA signaling may have far different out-
comes at differing times of development within the same
tissue. While our results indicate that a signal(s) from the
epicardium is necessary for both the proliferation and sur-
vival of the adjacent myocardium, it is unclear whether such
an epicardial signal is similarly required for survival of
adult myocardial cells, or for that matter, whether adult
myocardial cells, which are postmitotic, can respond to the
mitogenic activity of the embryonic epicardium. Indeed, a
recent study from Henry Sucov’s group suggests that car-
diac myocytes from postnatal mice are not responsive to the
epicardial mitogen (Chen et al., 2002).
The utilization of epo, an erythropoietic growth and
differentiation factor, for regulating heart size is potentially
intriguing from a physiologic and perhaps an evolutionary
standpoint. We speculate that it might be advantageous to
modulate the heart size of an animal according to the oxy-
genation status during fetal development. As it is known
that epo in the liver is stimulated by Hypoxia inducible
factor, HIF-1 (Ebert and Bunn, 1999), it is possible that a
systemic increase in epo levels, following oxygen depriva-
tion during fetal development, could both increase rates of
erythropoiesis and also increase myocardial cell prolifera-
tion. Both outcomes of epo signaling would act to improve
the oxygenation status of the developing tissues, by in-
creased erythropoiesis and by increased tissue perfusion,
respectively. An understanding of how epo signaling inde-
pendently regulates blood cell development or heart growth
Fig. 10. Retinoic acid and erythropoietin signaling in the epicardium work
in parallel to induce the secretion of a soluble mitogen or mitogens (termed
“X” and “Y”) from the epicardium, which stimulates cardiac myocyte
proliferation in the adjacent myocardium.
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awaits further characterization of the molecular pathways
regulating each of these effects.
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